Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;4(12):3932-51.
doi: 10.3390/v4123932.

The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment

Affiliations
Review

The impact of regulations, safety considerations and physical limitations on research progress at maximum biocontainment

Amy C Shurtleff et al. Viruses. 2012 Dec.

Abstract

We describe herein, limitations on research at biosafety level 4 (BSL-4) containment laboratories, with regard to biosecurity regulations, safety considerations, research space limitations, and physical constraints in executing experimental procedures. These limitations can severely impact the number of collaborations and size of research projects investigating microbial pathogens of biodefense concern. Acquisition, use, storage, and transfer of biological select agents and toxins (BSAT) are highly regulated due to their potential to pose a severe threat to public health and safety. All federal, state, city, and local regulations must be followed to obtain and maintain registration for the institution to conduct research involving BSAT. These include initial screening and continuous monitoring of personnel, controlled access to containment laboratories, accurate and current BSAT inventory records. Safety considerations are paramount in BSL-4 containment laboratories while considering the types of research tools, workflow and time required for conducting both in vivo and in vitro experiments in limited space. Required use of a positive-pressure encapsulating suit imposes tremendous physical limitations on the researcher. Successful mitigation of these constraints requires additional time, effort, good communication, and creative solutions. Test and evaluation of novel vaccines and therapeutics conducted under good laboratory practice (GLP) conditions for FDA approval are prioritized and frequently share the same physical space with important ongoing basic research studies. The possibilities and limitations of biomedical research involving microbial pathogens of biodefense concern in BSL-4 containment laboratories are explored in this review.

PubMed Disclaimer

Similar articles

Cited by

References

    1. CDC. Biosafety in Microbiological and Biomedical Laboratories. U. S. Department of Health and Human Services; Washington, DC, USA: 2009.
    1. NIAID. NIAID Biodefense Research Agenda for CDC Category A Agents. In Services, United States Department of Health and Human Services, National Institutes of Health; Bethesda, MD, USA: 2002.
    1. Pastel R.H., Demmin G., Severson G., Torres-Cruz R., Trevino J., Kelly J., Arrison J., Christman J. Clinical laboratories, the select agent program, and biological surety (biosurety) Clin. Lab. Med. 2006;26:299–312. doi: 10.1016/j.cll.2006.03.004. - DOI - PubMed
    1. Carr K., Henchal E.A., Wilhelmsen C., Carr B. Implementation of biosurety systems in a Department of Defense medical research laboratory. Biosecur. Bioterror. 2004;2:7–16. doi: 10.1089/153871304322964291. - DOI - PubMed
    1. National Select Agent Registry. [(accessed on 12 December 2012)]. Available online: http://www.selectagents.gov.

MeSH terms

LinkOut - more resources